Genomtec SA, a leading molecular diagnostics company headquartered in Wrocław (WSE ticker: GMT), announced today that it has filed a patent application with the British Patent Office for an innovative technology for the diagnosis of single-nucleotide genetic changes. The Company’s strategy includes extending patent protection under the international PCT procedure.